chr22-21772971-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_002745.5(MAPK1):āc.868T>Cā(p.Leu290=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,611,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.00037 ( 0 hom., cov: 32)
Exomes š: 0.000083 ( 0 hom. )
Consequence
MAPK1
NM_002745.5 synonymous
NM_002745.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.998
Genes affected
MAPK1 (HGNC:6871): (mitogen-activated protein kinase 1) This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 22-21772971-A-G is Benign according to our data. Variant chr22-21772971-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2652948.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 57 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAPK1 | NM_002745.5 | c.868T>C | p.Leu290= | synonymous_variant | 7/9 | ENST00000215832.11 | NP_002736.3 | |
MAPK1 | NM_138957.3 | c.868T>C | p.Leu290= | synonymous_variant | 7/8 | NP_620407.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAPK1 | ENST00000215832.11 | c.868T>C | p.Leu290= | synonymous_variant | 7/9 | 1 | NM_002745.5 | ENSP00000215832 | P1 | |
MAPK1 | ENST00000398822.7 | c.868T>C | p.Leu290= | synonymous_variant | 7/8 | 1 | ENSP00000381803 | P1 | ||
MAPK1 | ENST00000544786.1 | c.736T>C | p.Leu246= | synonymous_variant | 6/7 | 1 | ENSP00000440842 |
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 152166Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
57
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251478Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135914
GnomAD3 exomes
AF:
AC:
30
AN:
251478
Hom.:
AF XY:
AC XY:
8
AN XY:
135914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000829 AC: 121AN: 1459294Hom.: 0 Cov.: 28 AF XY: 0.0000757 AC XY: 55AN XY: 726198
GnomAD4 exome
AF:
AC:
121
AN:
1459294
Hom.:
Cov.:
28
AF XY:
AC XY:
55
AN XY:
726198
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000374 AC: 57AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.000389 AC XY: 29AN XY: 74458
GnomAD4 genome
AF:
AC:
57
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
29
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
MAPK1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | MAPK1: BP4, BP7, BS1 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at